Fexicaine
- Level
- Commodity
- Parent
- 51271600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51271611This classification denotes an anesthetic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5N2K83R1L2. European Medicines Agency schedules Fexicaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07617MIG. Fexicaine generally arises in the molecular formula C25H34N2O4. The term FEXICAINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , no. 10 1971, list 11.) FEXICAINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fexicaine under HS 29339990 and SITC 51577. As of Q4 2014, FEXICAINE remains the US FDA Preferred Term for this commodity. Fexicaine bears US NLM identifiers UMLS ID C1880766 and NCI Concept Code C65679. SMILES: O=C(N(CCN1CCCC1)C1C(OC)CCCC1)COC1CCC(OCCCC)CC1.
Same parent
Under 51271600 · 36Activities that produce or sell this
KBLI · 8Inherited from family 51270000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.